<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is a potentially life-threatening condition with a high mortality rate, the diagnosis of which requires a high degree of clinical awareness on the part of attending physicians </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with this syndrome have various symptoms in common: clinical evidence of multiple organ involvement developed over a very short time period, histopathological evidence of multiple small-vessel occlusions and laboratory confirmation of the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, usually in high titers </plain></SENT>
<SENT sid="2" pm="."><plain>The combination of high doses of intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi>, steroids, gamma-globulins and/or repeated plasma exchanges are the basic treatment of choice for <z:hpo ids='HP_0000001'>all</z:hpo> patients with this severe condition </plain></SENT>
</text></document>